CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $168K invested in Can-Fite BioPharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
RhumbLine Advisers
Boston,
Massachusetts
|
$52.5K |
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
3 |
3
Morgan Stanley
New York
|
$102K |